Answers are grounded in this paper and cite their sources.
Identifies XIRP1's role in targeting cytosolic bacteria in immune cells, suggesting a new defense mechanism.
Interferon-gamma (IFN-γ) is a powerful transactivating signal eliciting hundreds of IFN-stimulated genes (ISGs) in humans to help combat infection. Most ISGs remain uncharacterized, and here we searched for actin-binding candidates that could potentially target intracellular pathogens to block their spread or promote immune cell migration into infected tissues. Dual RNA-Seq and in silico mining across 1,933 data sets discovered >225 actin-related genes; the most highly expressed was XIRP1 (xin actin binding repeat containing 1 protein), a new ISG with no reported immune function. We found XIRP1 induction required IFN-γ plus IL-1β or exposure to pathogenic Listeria, Shigella, or Salmonella in immune and non-immune cells. Within IFN-γ-activated human macrophages, the XIRP1 protein localized to actin-rich podosomes where it formed a dome-shaped cap facing the cytosol; genetic XIRP1 ablation led to significant actin loss from these structures. Within infected cells, XIRP1 was recruited onto cytosolic Listeria monocytogenes in an ActA-dependent manner. Live imaging found many listeriae were fully encapsulated by XIRP1 whereas incomplete XIRP1 coating allowed pathogen escape from the initial coat structure. Together, our results identify XIRP1 as a new podosome-associated ISG that targets cytosolic bacteria as part of the IFN-γ-induced defense program in humans.
No takes yet. Share an insight, caveat, or question.
Urbano et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: